{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:09:15Z","timestamp":1786115355443,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Clinical Trials from Nanjing Drum Tower Hospital","award":["2025-LCYJ-PY-14"],"award-info":[{"award-number":["2025-LCYJ-PY-14"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330055"],"award-info":[{"award-number":["82330055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Province\u2019s Major Project in Research and Development","award":["BE2021689"],"award-info":[{"award-number":["BE2021689"]}]},{"name":"the Key Projects of the Jiangsu Basic Research Program","award":["BK20243061"],"award-info":[{"award-number":["BK20243061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04583-z","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:16:01Z","timestamp":1780413361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CCR2-overexpressing mesenchymal stromal cell-derived extracellular vesicles loaded with MPA ameliorate lupus nephritis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Hang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"17","key":"4583_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. JAMA. 2024;331(17):1480\u201391.","journal-title":"JAMA"},{"issue":"3","key":"4583_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, et al. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023;82(3):351\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"4583_CR3","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.autrev.2023.103404","volume":"22","author":"M Xipell","year":"2023","unstructured":"Xipell M, et al. From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmun Rev. 2023;22(10):103404.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4583_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016;55(2):252\u201362.","journal-title":"Rheumatology (Oxford)"},{"issue":"1S","key":"4583_CR5","first-page":"pS1","volume":"105","author":"G Kidney Disease: Improving Global Ou","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes Lupus Nephritis Work G. KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS. Kidney Int. 2024;105(1S):pS1\u2013S69.","journal-title":"Kidney Int"},{"issue":"7","key":"4583_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ndt\/gfaa267","volume":"37","author":"H Hendra","year":"2022","unstructured":"Hendra H, Salama AD. Steroids as treatment for glomerulonephritis: time for a rethink. Nephrol Dial Transpl. 2022;37(7):1212\u20137.","journal-title":"Nephrol Dial Transpl"},{"key":"4583_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-025-01242-0","author":"M Scherlinger","year":"2025","unstructured":"Scherlinger M, et al. Advances in the treatment of systemic lupus erythematosus. Nat Rev Drug Discov. 2025. https:\/\/doi.org\/10.1038\/s41573-025-01242-0.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"4583_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel TT, et al. The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov. 2010;9(4):325\u201338.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4583_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/art.27233","volume":"62","author":"JT Merrill","year":"2010","unstructured":"Merrill JT, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010;62(1):222\u201333.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"4583_CR10","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/S2665-9913(20)30355-6","volume":"3","author":"SZ Sheikh","year":"2021","unstructured":"Sheikh SZ, et al. Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial. Lancet Rheumatol. 2021;3(2):e122\u201330.","journal-title":"Lancet Rheumatol"},{"issue":"10381","key":"4583_CR11","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(22)02546-6","volume":"401","author":"M Petri","year":"2023","unstructured":"Petri M, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II). Lancet. 2023;401(10381):1011\u20139.","journal-title":"Lancet"},{"issue":"7","key":"4583_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748\u201359.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"4583_CR13","doi-asserted-by":"publisher","first-page":"e2200925","DOI":"10.1002\/smtd.202200925","volume":"7","author":"T Fang","year":"2023","unstructured":"Fang T, et al. Engineered cell membrane vesicles expressing CD40 alleviate system Lupus Nephritis by intervening B cell activation. Small Methods. 2023;7(3):e2200925.","journal-title":"Small Methods"},{"issue":"7","key":"4583_CR14","doi-asserted-by":"publisher","first-page":"8824","DOI":"10.1021\/acsami.1c23429","volume":"14","author":"H Fang","year":"2022","unstructured":"Fang H, et al. Macrophage-Targeted Hydroxychloroquine Nanotherapeutics for Rheumatoid Arthritis Therapy. ACS Appl Mater Interfaces. 2022;14(7):8824\u201337.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"4583_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cell.2020.02.001","volume":"181","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, et al. Targeting Strategies for Tissue-Specific Drug Delivery. Cell. 2020;181(1):151\u201367.","journal-title":"Cell"},{"issue":"3","key":"4583_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson A. What is damaging the kidney in Lupus nephritis? Nat Rev Rheumatol. 2016;12(3):143\u201353.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"4583_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ki.2011.354","volume":"81","author":"X Zhang","year":"2012","unstructured":"Zhang X, et al. A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int. 2012;81(4):401\u20136.","journal-title":"Kidney Int"},{"issue":"12","key":"4583_CR18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.190.12.1813","volume":"190","author":"GH Tesch","year":"1999","unstructured":"Tesch GH, et al. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med. 1999;190(12):1813\u201324.","journal-title":"J Exp Med"},{"issue":"6","key":"4583_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano S, et al. Precision medicine in systemic lupus erythematosus. Nat Rev Rheumatol. 2023;19(6):331\u201342.","journal-title":"Nat Rev Rheumatol"},{"key":"4583_CR20","doi-asserted-by":"crossref","unstructured":"Mysore V et al. Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. J Exp Med, 2022. 219(5):e20210562.","DOI":"10.1084\/jem.20210562"},{"issue":"2","key":"4583_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/path.6331","volume":"264","author":"T Zoshima","year":"2024","unstructured":"Zoshima T, et al. The CCL2-CCR2 axis determines whether glomerular endocapillary hypercellularity or wire-loop lesions develop through glomerular macrophage and neutrophil infiltration in lupus nephritis. J Pathol. 2024;264(2):174\u201385.","journal-title":"J Pathol"},{"issue":"1\u20132","key":"4583_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cellimm.2012.06.010","volume":"278","author":"S Liu","year":"2012","unstructured":"Liu S, et al. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton\u2019s jelly and derived cartilage cells. Cell Immunol. 2012;278(1\u20132):35\u201344.","journal-title":"Cell Immunol"},{"issue":"33","key":"4583_CR23","doi-asserted-by":"publisher","first-page":"e2403199","DOI":"10.1002\/adma.202403199","volume":"36","author":"Y Xia","year":"2024","unstructured":"Xia Y, et al. Immunogenicity of Extracellular Vesicles. Adv Mater. 2024;36(33):e2403199.","journal-title":"Adv Mater"},{"issue":"12","key":"4583_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.5966\/sctm.2012-0086","volume":"1","author":"P Lin","year":"2012","unstructured":"Lin P, et al. Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. Stem Cells Transl Med. 2012;1(12):886\u201397.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"4583_CR25","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"4583_CR26","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1021\/cr068020s","volume":"107","author":"Y Wan","year":"2007","unstructured":"Wan Y, Zhao D. On the controllable soft-templating approach to mesoporous silicates. Chem Rev. 2007;107(7):2821\u201360.","journal-title":"Chem Rev"},{"issue":"4","key":"4583_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1523-1755.2002.kid572.x","volume":"62","author":"U Haberstroh","year":"2002","unstructured":"Haberstroh U, et al. Expression of the chemokines MCP-1\/CCL2 and RANTES\/CCL5 is differentially regulated by infiltrating inflammatory cells. Kidney Int. 2002;62(4):1264\u201376.","journal-title":"Kidney Int"},{"key":"4583_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1993.tb00652.x","author":"AC Allison","year":"1993","unstructured":"Allison AC, Eugui EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev. 1993. https:\/\/doi.org\/10.1111\/j.1600-065X.1993.tb00652.x.","journal-title":"Immunol Rev"},{"issue":"5","key":"4583_CR29","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1093\/rheumatology\/keae517","volume":"64","author":"EA Morris","year":"2025","unstructured":"Morris EA, et al. Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages. Rheumatology (Oxford). 2025;64(5):3125\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4583_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/cimb45010038","volume":"45","author":"DS Chulpanova","year":"2023","unstructured":"Chulpanova DS, et al. Cytochalasin B-Induced Membrane Vesicles from TRAIL-Overexpressing Mesenchymal Stem Cells Induce Extrinsic Pathway of Apoptosis in Breast Cancer Mouse Model. Curr Issues Mol Biol. 2023;45(1):571\u201392.","journal-title":"Curr Issues Mol Biol"},{"key":"4583_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813689","author":"A Fracchia","year":"2023","unstructured":"Fracchia A, et al. Mesenchymal stromal cell-derived small extracellular vesicles modulate apoptosis, TNF Alpha and Interferon Gamma response gene mRNA expression in T lymphocytes. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241813689.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4583_CR32","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1046\/j.1523-1755.2002.00357.x","volume":"61","author":"GS Hill","year":"2002","unstructured":"Hill GS, et al. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 2002;61(6):2176\u201386.","journal-title":"Kidney Int"},{"issue":"2","key":"4583_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","volume":"107","author":"AS De Vriese","year":"2024","unstructured":"De Vriese AS, Sethi S, Fervenza FC. Lupus nephritis: redefining the treatment goals. Kidney Int. 2024;107(2):198\u2013211.","journal-title":"Kidney Int"},{"issue":"5","key":"4583_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/ard.33.5.473","volume":"33","author":"DG Scott","year":"1974","unstructured":"Scott DG, Rowell NR. Immunohistological studies of the kidney in systemic lupus erythematosus and systemic sclerosis using antisera to IgG, C3, fibrin, and human renal glomeruli. Ann Rheum Dis. 1974;33(5):473\u201381.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"4583_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-021-04052-5","volume":"12","author":"D Li","year":"2021","unstructured":"Li D, et al. C-type lectin receptor Dectin3 deficiency balances the accumulation and function of FoxO1-mediated LOX-1\u2009+\u2009M-MDSCs in relieving lupus-like symptoms. Cell Death Dis. 2021;12(9):829.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4583_CR36","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1039\/C7BM00271H","volume":"5","author":"J Wang","year":"2017","unstructured":"Wang J, Masehi-Lano JJ, Chung EJ. Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease. Biomater Sci. 2017;5(8):1450\u20139.","journal-title":"Biomater Sci"},{"issue":"3","key":"4583_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1681\/ASN.0000000608","volume":"36","author":"A Roointan","year":"2024","unstructured":"Roointan A, et al. Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions. J Am Soc Nephrology: JASN. 2024;36(3):500\u201318.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"4583_CR38","doi-asserted-by":"publisher","first-page":"121517","DOI":"10.1016\/j.biomaterials.2022.121517","volume":"285","author":"Q Guo","year":"2022","unstructured":"Guo Q, et al. Engineered PD-1\/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell\/Treg balance and alleviate systemic lupus erythematosus. Biomaterials. 2022;285:121517.","journal-title":"Biomaterials"},{"issue":"35","key":"4583_CR39","doi-asserted-by":"publisher","first-page":"e2303835","DOI":"10.1002\/adma.202303835","volume":"35","author":"L Tang","year":"2023","unstructured":"Tang L, et al. Extracellular Vesicles-Derived Hybrid Nanoplatforms for Amplified CD47 Blockade-Based Cancer Immunotherapy. Adv Mater. 2023;35(35):e2303835.","journal-title":"Adv Mater"},{"key":"4583_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2018.11.004","volume":"98","author":"SA Chalmers","year":"2019","unstructured":"Chalmers SA, et al. NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis. J Autoimmun. 2019;98:33\u201343.","journal-title":"J Autoimmun"},{"issue":"6","key":"4583_CR41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805\u201320.","journal-title":"Cell"},{"issue":"1","key":"4583_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","volume":"10","author":"R Chen","year":"2025","unstructured":"Chen R, et al. Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Ther. 2025;10(1):216.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4583_CR43","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.immuni.2024.03.005","volume":"57","author":"C Reis e Sousa","year":"2024","unstructured":"Reis e Sousa C, Yamasaki S, Brown GD. Myeloid C-type lectin receptors in innate immune recognition. Immunity. 2024;57(4):700\u201317.","journal-title":"Immunity"},{"issue":"31","key":"4583_CR44","doi-asserted-by":"publisher","first-page":"25964","DOI":"10.1074\/jbc.M112.384164","volume":"287","author":"LM Graham","year":"2012","unstructured":"Graham LM, et al. The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase. J Biol Chem. 2012;287(31):25964\u201374.","journal-title":"J Biol Chem"},{"issue":"21","key":"4583_CR45","doi-asserted-by":"publisher","first-page":"e2210392","DOI":"10.1002\/adma.202210392","volume":"35","author":"R Xu","year":"2023","unstructured":"Xu R, et al. An Engineered Nanosugar Enables Rapid and Sustained Glucose-Responsive Insulin Delivery in Diabetic Mice. Adv Mater (Deerfield Beach Fla). 2023;35(21):e2210392.","journal-title":"Adv Mater (Deerfield Beach Fla)"},{"key":"4583_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bioactmat.2025.10.042","volume":"57","author":"L Ren","year":"2026","unstructured":"Ren L, et al. A polymeric triple-enzyme nanoparticle by light activatable crosslinking for cascade catalytic therapy of osteosarcoma. Bioactive Mater. 2026;57:93\u2013104.","journal-title":"Bioactive Mater"},{"issue":"9","key":"4583_CR47","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of Systemic Lupus Erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4583_CR48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04583-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:08:55Z","timestamp":1785982135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4583"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04583-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"723"}}